BIO 主要統計
高い
307.10
オープン
301.00
取引高
275.06K
低い
298.74
前日終値
301.70
売買代金
84.03M
52週高値
343.12
相対取引高
0.897
変動幅 (%)
2.77%
52週安値
236.73
売買回転率
1.27%
時価総額
8.18B
PER（TTM）
50.37
PER（年次）
10.978
PBR
1.2
PSR
3.16
1株当たり利益（EPS）
6.075
配当（TTM）
0
配当利回り
0.00%
発行済株式数
21.70M
通貨単位
USD
BIO 価格パフォーマンス
7 日
30 日
90 日
180 日
年初来
1 年
BIO マネーフロー分布
BIO 日次空売り出来高
BIO ショートインタレスト履歴
BIO 株式スナップショット
As of 2026-07-23, the Bio-Rad Laboratories, Inc. (BIO) stock price today is 305.96. Based on this price, the company has a market capitalization of $8.18B, with a P/E ratio of 50.37.
On 2026-07-23, BIO traded between 298.74 and 307.10. Today’s stock price is 2.42% above the daily low and 0.37% below the daily high, placing BIO 上限付近 its most recent trading range.
Trading volume currently stands at 275.06K, compared with an average daily volume of 306.76K. This suggests that trading activity is 通常水準とほぼ同じ than usual.
Over the past year, Bio-Rad Laboratories, Inc. shares have traded between 236.73 and 343.12. At today’s price, BIO is 29.24% above its 52-week low and 10.83% below its 52-week high.
BIO 関連ニュース
について BIO
企業名
Bio-Rad Laboratories, Inc.
セクター
Health Technology
業種
Medical Specialties
取引所
NYSE
従業員数
7,450
ロットサイズ
40
公式サイト
通貨単位
USD
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Related Stocks
